Detalhe da pesquisa
1.
Low incidence of severe acute and chronic graft-versus-host disease in a long-term retrospective study with ATG Grafalon routine use.
Ann Hematol
; 102(12): 3587-3591, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37783854
2.
Successful therapy of retroperitoneal fibrosis due to IgG4-related disease with rituximab, cyclophosphamide and glucocorticoids followed by maintenance therapy wit ritutixmab.
Vnitr Lek
; 69(E-3): 4-15, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468330
3.
CAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity.
Neoplasma
; 69(5): 1008-1018, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35900317
4.
Langerhans cell histiocytosis (LCH). Overview of symptoms of LCH, which may lead the patients to any of these medical specialists.
Vnitr Lek
; 68(E-2): 11-21, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36208940
5.
IgG4-related disease. Clinical manifestation differential diagnosis and recent International Diagnostic Criteria for IgG4-related disease.
Vnitr Lek
; 68(E-5): 4-19, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36283812
6.
Multicentric Castlemans disease. Symptoms, diagnostics and therapy.
Vnitr Lek
; 68(1): 41-53, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35459346
7.
Therapy of immunoglonuline IgG4 related disease (IgG4-RD).
Vnitr Lek
; 68(E-6): 15-22, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316207
8.
Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience.
Ann Hematol
; 100(10): 2541-2546, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34309714
9.
Prognostic significance of lymphocyte patterns in multiple myeloma patients after autologous transplant.
Neoplasma
; 68(3): 519-527, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33618517
10.
Lymphangiomatosis - very rare disease of the lymphatic vessels.
Vnitr Lek
; 67(E-4): 9-12, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34275313
11.
Unicentric Castlemans disease. Symptoms, diagnostics and therapy.
Vnitr Lek
; 67(8): 465-473, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35459366
12.
Therapy of 3 patients with Erdhiem-Chester disease with cladribin or cladribin in combination with cyclophosphamide. Case report and review of the therapy.
Vnitr Lek
; 67(3): 157-164, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171955
13.
Hereditary hemorrhagic telangiectasia (OslerWeberRendu syndrome) - Part II. Pharmacological therapy and international guidelines for the therapy 2020.
Vnitr Lek
; 67(7): 419-424, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35459360
14.
Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome) Part I. Pathophysiology, clinical symptoms and recommend screening for vascular malformations.
Vnitr Lek
; 67(6): 339-344, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35459376
15.
Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone.
Vnitr Lek
; 67(6): 352-356, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35459378
16.
Transformation of IgM-MGUS into Waldenström´s macroglobulinemia in two of six patients treated for Schnitzler´s syndrome.
Vnitr Lek
; 67(E-3): 15-23, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34171947
17.
Histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Comparison of recent WHO classification published 2017 and classification of Histiocyte Society published 2016.
Vnitr Lek
; 66(6): 19-27, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33380149
18.
Systemic inflammatory response with high CRP values as the dominant symptom of multiple myeloma.
Vnitr Lek
; 65(1): 37-44, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30823836
19.
Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 study.
Lancet Oncol
; 19(3): 370-381, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29429912
20.
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.
Biol Blood Marrow Transplant
; 24(5): 930-936, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29339268